Healthcare provider profile · identity verified

Christopher M Beard, MD

Family Practice · MARYSVILLE, WA · NPI 1144296575

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	418	140
Lisinopril	Lisinopril	333	114
Levothyroxine Sodium	Levothyroxine Sodium	264	77
Omeprazole	Omeprazole	236	81
Amlodipine Besylate	Amlodipine Besylate	196	70
Tamsulosin Hcl	Tamsulosin Hcl	170	59
Gabapentin	Gabapentin	161	44
Losartan Potassium	Losartan Potassium	135	47
Sertraline Hcl	Sertraline Hcl	134	46
Metformin Hcl Er	Metformin Hcl	131	43
Metoprolol Succinate	Metoprolol Succinate	117	39
Rosuvastatin Calcium	Rosuvastatin Calcium	112	36
Hydrochlorothiazide	Hydrochlorothiazide	110	40
Lovastatin	Lovastatin	99	30
Atenolol	Atenolol	87	26
Metformin Hcl	Metformin Hcl	83	34
Trazodone Hcl	Trazodone Hcl	77	22
Alprazolam	Alprazolam	73	19
Albuterol Sulfate Hfa	Albuterol Sulfate	71	38
Pantoprazole Sodium	Pantoprazole Sodium	71	26
Allopurinol	Allopurinol	70	25
Metoprolol Tartrate	Metoprolol Tartrate	68	21
Spironolactone	Spironolactone	61	16
Potassium Chloride	Potassium Chloride	55	19
Fluticasone Propionate	Fluticasone Propionate	54	18
Pioglitazone Hcl	Pioglitazone Hcl	51	12
Furosemide	Furosemide	50	23
Duloxetine Hcl	Duloxetine Hcl	47	11
Simvastatin	Simvastatin	46	18
Dutasteride	Dutasteride	45	17
Famotidine	Famotidine	42	16
Pravastatin Sodium	Pravastatin Sodium	42	17
Tramadol Hcl	Tramadol Hcl	42	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	41	17
Naproxen	Naproxen	39	suppressed
Clopidogrel	Clopidogrel Bisulfate	38	11
Ezetimibe	Ezetimibe	38	15
Alendronate Sodium	Alendronate Sodium	37	13
Glipizide Er	Glipizide	37	15
Clonazepam	Clonazepam	35	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	35	suppressed
Donepezil Hcl	Donepezil Hcl	34	suppressed
Meloxicam	Meloxicam	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Ketoconazole	Ketoconazole	32	17
Tizanidine Hcl	Tizanidine Hcl	31	12
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Amoxicillin	Amoxicillin	28	20
Finasteride	Finasteride	28	suppressed
Ozempic	Semaglutide	28	suppressed
Terbinafine Hcl	Terbinafine Hcl	28	suppressed
Topiramate	Topiramate	28	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	27	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	27	16
Montelukast Sodium	Montelukast Sodium	27	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	27	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Prednisone	Prednisone	26	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	25	suppressed
Cephalexin	Cephalexin	24	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Glimepiride	Glimepiride	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Nitroglycerin	Nitroglycerin	23	13
Sildenafil Citrate	Sildenafil Citrate	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	19
Fenofibrate	Fenofibrate	22	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Risperidone	Risperidone	22	suppressed
Warfarin Sodium	Warfarin Sodium	22	suppressed
Lidocaine	Lidocaine	21	suppressed
Arnuity Ellipta	Fluticasone Furoate	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	20	12
Azithromycin	Azithromycin	19	15
Eliquis	Apixaban	19	suppressed
Gemfibrozil	Gemfibrozil	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Baclofen	Baclofen	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Carvedilol	Carvedilol	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Valsartan	Valsartan	17	suppressed
Estradiol	Estradiol	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Jardiance	Empagliflozin	15	suppressed
Methylprednisolone	Methylprednisolone	15	11
Symbicort	Budesonide/Formoterol Fumarate	15	suppressed
Azelastine Hcl	Azelastine Hcl	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Repatha Sureclick	Evolocumab	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Digoxin	Digoxin	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	13	suppressed
Myrbetriq	Mirabegron	13	suppressed
Celecoxib	Celecoxib	12	suppressed
Metronidazole	Metronidazole	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Temazepam	Temazepam	12	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	11	suppressed
Torsemide	Torsemide	11	suppressed
Trulicity	Dulaglutide	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error